NewLimit
@newlimitbio.bsky.social
NewLimit has raised a $130M Series B led by Kleiner Perkins alongside NFDG, @khoslaventures.bsky.social, Human Capital and returning investors Dimension & Founders Fund
We're grateful for their boldness in joining us on our journey to extend human healthspan
blog.newlimit.com/p/newlimit-r...
We're grateful for their boldness in joining us on our journey to extend human healthspan
blog.newlimit.com/p/newlimit-r...
NewLimit raises $130 million Series B led by Kleiner Perkins alongside NFDG, Khosla Ventures, Human Capital and others
NewLimit is developing medicines to extend human healthspan through epigenetic reprogramming
blog.newlimit.com
May 6, 2025 at 9:55 PM
NewLimit has raised a $130M Series B led by Kleiner Perkins alongside NFDG, @khoslaventures.bsky.social, Human Capital and returning investors Dimension & Founders Fund
We're grateful for their boldness in joining us on our journey to extend human healthspan
blog.newlimit.com/p/newlimit-r...
We're grateful for their boldness in joining us on our journey to extend human healthspan
blog.newlimit.com/p/newlimit-r...
Reposted by NewLimit
each year @newlimitbio.bsky.social, we share an update on our progress with the public
this week, we revealed the early results from our programs in metabolism & immunology. we’re starting to see the first hints of reprogramming medicines on the horizon.
watch here: m.youtube.com/watch?v=HR0-...
this week, we revealed the early results from our programs in metabolism & immunology. we’re starting to see the first hints of reprogramming medicines on the horizon.
watch here: m.youtube.com/watch?v=HR0-...
NewLimit Progress Update 2025
YouTube video by NewLimit
m.youtube.com
March 23, 2025 at 6:07 AM
each year @newlimitbio.bsky.social, we share an update on our progress with the public
this week, we revealed the early results from our programs in metabolism & immunology. we’re starting to see the first hints of reprogramming medicines on the horizon.
watch here: m.youtube.com/watch?v=HR0-...
this week, we revealed the early results from our programs in metabolism & immunology. we’re starting to see the first hints of reprogramming medicines on the horizon.
watch here: m.youtube.com/watch?v=HR0-...
Reposted by NewLimit
2024 @newlimitbio.bsky.social:
- 10X Engine throughput
- Discovered TF sets that reprogram cell age & preserve type
- Restored youthful function in a disease model with drug-like reprogramming
we demonstrated that reprogramming medicines are possible
2025: we start to develop them
bit.ly/4h7rrD3
- 10X Engine throughput
- Discovered TF sets that reprogram cell age & preserve type
- Restored youthful function in a disease model with drug-like reprogramming
we demonstrated that reprogramming medicines are possible
2025: we start to develop them
bit.ly/4h7rrD3
2024 Year in Review
Restoring youthful function
bit.ly
January 9, 2025 at 5:12 PM
2024 @newlimitbio.bsky.social:
- 10X Engine throughput
- Discovered TF sets that reprogram cell age & preserve type
- Restored youthful function in a disease model with drug-like reprogramming
we demonstrated that reprogramming medicines are possible
2025: we start to develop them
bit.ly/4h7rrD3
- 10X Engine throughput
- Discovered TF sets that reprogram cell age & preserve type
- Restored youthful function in a disease model with drug-like reprogramming
we demonstrated that reprogramming medicines are possible
2025: we start to develop them
bit.ly/4h7rrD3
Reposted by NewLimit
early autumn @newlimitbio.bsky.social:
- 0 → 70 TF sets tested in human hepatocytes via a chimeric liver system
- +2779 TF sets tested in T cells
- +51 sets that reverse phenotypic age in T cells
- 5 → 7 functional assays for hepatocyte age
- 0 → 80% efficiency LNP-mRNA delivery
bit.ly/4g0NKJV
- 0 → 70 TF sets tested in human hepatocytes via a chimeric liver system
- +2779 TF sets tested in T cells
- +51 sets that reverse phenotypic age in T cells
- 5 → 7 functional assays for hepatocyte age
- 0 → 80% efficiency LNP-mRNA delivery
bit.ly/4g0NKJV
September // October 2024 Progress Update
In chimerico reprogramming
blog.newlimit.com
November 23, 2024 at 6:16 PM
early autumn @newlimitbio.bsky.social:
- 0 → 70 TF sets tested in human hepatocytes via a chimeric liver system
- +2779 TF sets tested in T cells
- +51 sets that reverse phenotypic age in T cells
- 5 → 7 functional assays for hepatocyte age
- 0 → 80% efficiency LNP-mRNA delivery
bit.ly/4g0NKJV
- 0 → 70 TF sets tested in human hepatocytes via a chimeric liver system
- +2779 TF sets tested in T cells
- +51 sets that reverse phenotypic age in T cells
- 5 → 7 functional assays for hepatocyte age
- 0 → 80% efficiency LNP-mRNA delivery
bit.ly/4g0NKJV
Reposted by NewLimit
late summer @newlimit
- world's largest partial reprogramming screen (again)
- 3x'd speed of sequencing turn-around
- 5x'd reprog factor library size
- built our first integrated reprog corpus for model training
- team += 3
blog.newlimit.com/p/july-augus...
- world's largest partial reprogramming screen (again)
- 3x'd speed of sequencing turn-around
- 5x'd reprog factor library size
- built our first integrated reprog corpus for model training
- team += 3
blog.newlimit.com/p/july-augus...
July-August 2023 Progress Update
Recursive record setting
blog.newlimit.com
September 9, 2023 at 5:09 PM
late summer @newlimit
- world's largest partial reprogramming screen (again)
- 3x'd speed of sequencing turn-around
- 5x'd reprog factor library size
- built our first integrated reprog corpus for model training
- team += 3
blog.newlimit.com/p/july-augus...
- world's largest partial reprogramming screen (again)
- 3x'd speed of sequencing turn-around
- 5x'd reprog factor library size
- built our first integrated reprog corpus for model training
- team += 3
blog.newlimit.com/p/july-augus...